Clinical Trial Update: BR in Patients With CLL With Comorbidities and/or Renal Dysfunction [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the bendamustine-rituximab (BR) regimen in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Treanda (Bendamustine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | Status: COMPLETED